# AbbVie Inc.: Form D filing

AbbVie Inc., a pharmaceuticals company in North Chicago, IL, filed a Form D with the SEC in 2016. The latest, on May 9, 2016, reports $3.80 billion sold of a $3.80 billion offering to 39 investors.

Find out what AbbVie Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20AbbVie%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=AbbVie%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fabbvie-inc-1551152)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20AbbVie%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=AbbVie%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fabbvie-inc-1551152)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Illinois](https://specstream.ai/data/form-d/state/illinois): 1,511 rows, by operating companies, filed since November 1, 2024, $75.55, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/illinois
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1 North Waukegan Road, North Chicago, IL, 60064
- Phone: (847) 932-7900
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2012
- Revenue range: Over $100,000,000
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1551152

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 9, 2016 | New notice | $3,800,000,000 | $3,800,000,000 | $0 | 39 | Apr 25, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1551152/000110465916119229/0001104659-16-119229-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Thomas A. Hurwich | Executive Officer |  |
| Edward M. Liddy | Director |  |
| Timothy J. Richmond | Executive Officer |  |
| Glenn F. Tilton | Director |  |
| Henry E. Gosebruch | Executive Officer |  |
| Azita J. Saleki-Gerhardt | Executive Officer |  |
| Roxanne S. Austin | Director |  |
| Michael E. Severino | Executive Officer |  |
| Frederick H. Waddell | Director |  |
| William J. Chase | Executive Officer |  |
| Richard A. Gonzalez | Executive Officer, Director |  |
| Robert J. Alpern | Director |  |
| William H.L. Burnside | Director |  |
| Brett J. Hart | Director |  |
| Carlos E. Alban | Executive Officer |  |
| Edward J. Rapp | Director |  |
| Laura J. Schumacher | Executive Officer |  |

[Every Form D from the week of May 9, 2016](https://specstream.ai/data/form-d/week/2016-05-09) · [All recent filings in Illinois](https://specstream.ai/data/form-d/state/illinois) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what AbbVie Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).